Morningstar Investor users sign in here.

Company Profile

  • Business description

    Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.

  • Contact

    225 Binney Street
    Cambridge MA 02142
    USA

    T: +1 617 679-2000

    E: IR@biogen.com

    https://www.biogen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    7,570

Stocks News & Analysis

stocks

Surge in ASX share may be overblown

After an acquisition bid for Premier’s Apparel Brands business Myer shares soared but the combination may exacerbate existing risk to the business.  
stocks

3 cheap Wide Moat stocks in a divided industry

All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far. 
stocks

3 industries to focus on for high quality investments

Some industries are moaty by nature. One that is deeply out of favour offers a prime example.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,975.10 64.80 -0.81%
CAC 40 7,706.89 78.32 1.03%
DAX 40 18,325.58 162.06 0.89%
Dow JONES (US) 39,411.21 260.88 0.67%
FTSE 100 8,281.55 43.83 0.53%
HKSE 18,027.71 0.81 -0.00%
NASDAQ 17,496.82 192.54 -1.09%
Nikkei 225 38,804.65 208.18 0.54%
NZX 50 Index 11,590.32 37.54 -0.32%
S&P 500 5,447.87 16.75 -0.31%
S&P/ASX 200 7,733.70 62.30 -0.80%
SSE Composite Index 2,963.10 35.04 -1.17%

Market Movers

Name
Last price
Change
% Change
Imugene Ltd IMU 0.06 0.00 -6.78%
Peninsula Energy Ltd PEN 0.10 0.02 -13.04%
Red 5 Ltd RED 0.41 0.01 -2.38%
Sayona Mining Ltd SYA 0.03 0.00 -2.86%
Cettire Ltd CTT 1.14 1.11 -49.33%
Liontown Resources Ltd LTR 0.91 0.03 -2.67%
Core Lithium Ltd CXO 0.08 0.00 -4.82%
Botanix Pharmaceuticals Ltd BOT 0.38 0.02 4.17%
Telstra Group Ltd TLS 3.62 0.04 -1.09%
Droneshield Ltd DRO 1.53 0.12 -7.01%